The market recently broke below the crucial support of the ascending trend line, and the significant gap down on August 5th remains unfilled, indicating a negative outlook. A decisive drop below 23,900 could lead to a short-term downward correction. The immediate resistance is at 24,250-24,300 levels, according to Nagaraj Shetti of HDFC Securities.
Dr. Reddy’s Laboratories Q1 Results: PAT rises 2% YoY to Rs 1,418 crore, revenue jumps 11%
Dr Reddy’s Laboratories Q1 Results: Pharma major Dr. Reddy’s Laboratories reported a marginal 2% year-on-year (YoY) growth in its consolidated net profit at Rs 1,418
July 23, 2025